Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Apr 19, 2010
Finance
Codexis decodes cost
...Enterprises (19.8%); the Economic Development Board of Singapore (12%); CMEA Ventures (10.7%); FirstMark Capital (formerly
Pequot Capital
...
Read More
BioCentury
|
Jan 4, 2010
Finance
VCs take over dalbavancin
...Enterprises (20%); the Economic Development Board of Singapore (12.1%); CMEA Ventures (10.8%); FirstMark Capital (formerly
Pequot Capital
...
Read More
BioCentury
|
Jan 4, 2010
Finance
Psychiatry play
...Enterprises (20%); the Economic Development Board of Singapore (12.1%); CMEA Ventures (10.8%); FirstMark Capital (formerly
Pequot Capital
...
Read More
BioCentury
|
Jul 28, 2008
Finance
Ebb & Flow
...fund at more than $500 million. In early July, Longitude Capital , spun out of
Pequot Capital
...
Read More
BioCentury
|
Jul 14, 2008
Finance
Ebb & Flow
...original $250 million target. The firm was formed in late 2006 as a spinout from
Pequot Capital
...
Read More
BioCentury
|
Jul 9, 2008
Top Story
Longitude closes $325M fund
...The firm, which will focus on biotech and medical device companies, was formed by former
Pequot Capital
...
Read More
BioCentury
|
Apr 21, 2008
Finance
Ebb & Flow
...the Economic Development Board of Singapore (14.1%); Royal Dutch Shell (13.4%); CMEA Ventures (12.6%); and
Pequot Capital
...
Read More
BioCentury
|
Mar 10, 2008
Finance
Ebb & Flow
...Oct. 9, 2006). Investors trimmed the stock $0.96 (33%) to $1.98 last week. VC watch
Pequot Capital
...
Read More
BioCentury
|
Mar 29, 2006
Financial News
Sequenom raises $30 million
...warrants to purchase 32.7 million shares at the same price. Investors included ComVest Investment Partners;
Pequot Capital
...
Read More
BioCentury
|
Mar 13, 2006
Product Development
BEST case scenario
...to and adverse effects of the compound. Three investors - Atlas Venture, Boulder Ventures and
Pequot Capital
...
Read More
Items per page:
10
1 - 10 of 21
BioCentury
|
Apr 19, 2010
Finance
Codexis decodes cost
...Enterprises (19.8%); the Economic Development Board of Singapore (12%); CMEA Ventures (10.7%); FirstMark Capital (formerly
Pequot Capital
...
Read More
BioCentury
|
Jan 4, 2010
Finance
VCs take over dalbavancin
...Enterprises (20%); the Economic Development Board of Singapore (12.1%); CMEA Ventures (10.8%); FirstMark Capital (formerly
Pequot Capital
...
Read More
BioCentury
|
Jan 4, 2010
Finance
Psychiatry play
...Enterprises (20%); the Economic Development Board of Singapore (12.1%); CMEA Ventures (10.8%); FirstMark Capital (formerly
Pequot Capital
...
Read More
BioCentury
|
Jul 28, 2008
Finance
Ebb & Flow
...fund at more than $500 million. In early July, Longitude Capital , spun out of
Pequot Capital
...
Read More
BioCentury
|
Jul 14, 2008
Finance
Ebb & Flow
...original $250 million target. The firm was formed in late 2006 as a spinout from
Pequot Capital
...
Read More
BioCentury
|
Jul 9, 2008
Top Story
Longitude closes $325M fund
...The firm, which will focus on biotech and medical device companies, was formed by former
Pequot Capital
...
Read More
BioCentury
|
Apr 21, 2008
Finance
Ebb & Flow
...the Economic Development Board of Singapore (14.1%); Royal Dutch Shell (13.4%); CMEA Ventures (12.6%); and
Pequot Capital
...
Read More
BioCentury
|
Mar 10, 2008
Finance
Ebb & Flow
...Oct. 9, 2006). Investors trimmed the stock $0.96 (33%) to $1.98 last week. VC watch
Pequot Capital
...
Read More
BioCentury
|
Mar 29, 2006
Financial News
Sequenom raises $30 million
...warrants to purchase 32.7 million shares at the same price. Investors included ComVest Investment Partners;
Pequot Capital
...
Read More
BioCentury
|
Mar 13, 2006
Product Development
BEST case scenario
...to and adverse effects of the compound. Three investors - Atlas Venture, Boulder Ventures and
Pequot Capital
...
Read More
Items per page:
10
1 - 10 of 21
Previous page
Next page